If you have pneumonitis with Keytruda, your doctor might prescribe corticosteroid treatment for you ... reaction can include swelling under your skin, typically in your eyelids, lips, hands ...

Moderna and Merck's experimental cancer vaccine, when used in combination with Keytruda ... a treatment for non-small cell lung cancer. Melanoma is responsible for the large majority of skin ...

The KEYNOTE-689 trial assessing Keytruda (pembrolizumab) for the perioperative treatment of newly diagnosed stage 3 or 4A, resected, locally advanced head and neck squamous cell carcinoma met its ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing ...

The US Food and Drug Administration (FDA) has approved MSD’s KEYTRUDA regimen as a first-line treatment for adults with unresectable advanced or metastatic malignant pleural mesothelioma (MPM).

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...

Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress ...

“These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...

Padcev is indicated in Japan as monotherapy for the treatment of adult patients with radically unresectable urothelial carcinoma that has progressed after anti-cancer chemotherapy, and in combination ...

Analysis of paired biopsies showed increased tumor infiltration of CD25+ activated CD8+ T cells and NK cells post-MDNA11 treatment. Combination Dose ... Cohort 3: 120 microgram/kg Q2W MDNA11 and 400 ...